Androstenedione
A4
Description
"Androstenedione" test measures this steroid hormone to assess adrenal and gonadal function. It’s commonly used when signs of hormone imbalance appear, such as irregular periods, excess hair growth, or acne. Elevated levels may suggest PCOS or adrenal hyperplasia, while low levels could reflect pituitary dysfunction. Doctors use this test to investigate fertility issues, monitor treatment, or explore endocrine disorders. Results help guide next steps in hormonal care and support diagnosis of reproductive or metabolic conditions.
Test Category
Hormones
Procedure
Invasive
Sample Type
Blood – Serum
Units
Nanograms Per Deciliter | Nanomoles Per Liter
Procedure Category
Blood Draw
Test Group
Hormone Health Group
Test Group Description
Hormone Health Group: Its focus is on evaluating hormone levels and function, providing insights into hormonal balance and associated health conditions.
Optimal Range
For Men:
Conventional Unit: Not Available
SI Unit: Not Available
For Women:
Conventional Unit: Not Available
SI Unit: Not Available
Normal Range
For Men:
Conventional Unit: 40.00–150.00 ng/dL
SI Unit: 1.40–5.23 nmol/L
For Women:
Conventional Unit: 30.00–200.00 ng/dL
SI Unit: 1.05–6.98 nmol/L
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
Adrenal cancer (Malignant tumor originating in the adrenal glands)
Adrenal hyperplasia (Overgrowth of adrenal gland tissue)
Adrenal tumor (Abnormal growth or mass in the adrenal glands)
Congenital adrenal hyperplasia (Genetic disorder causing abnormal hormone production in the adrenal glands)
...
Key Reasons For Testing
Evaluation of Androgen Production: Assesses how well the body produces androgens like testosterone.
PCOS Diagnosis: Identifies elevated androstenedione levels associated with polycystic ovary syndrome.
Adrenal Function Assessment: Evaluates adrenal gland activity, a key source of androstenedione.
Differential Diagnosis of Hyperandrogenism: Distinguishes whether elevated androgen levels stem from the adrenal glands or ovaries.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Casson PR, Rosenfield RL, Ross JL, et al. Androgen excess disorders in women: the role of androstenedione. J Clin Endocrinol Metab. 2000;85(3):789-799.
[2] Burger HG. Androgen production in women. Fertil Steril. 2002;77(Suppl 4):S3-S5.
[3] Gilling-Smith C, Willis DS, Beard RW, Franks S. Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. J Clin Endocrinol Metab. 1994;79(4):1158-1165.
[4] Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223-1236.
[5] Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: influence on the menopause and aging process. Endocr Rev. 2003;24(2):152-182.
[6] Hemsell DL, Grodin JM, Brenner PF, Siiteri PK, MacDonald PC. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab. 1974;38(3):476-479.
[7] Stewart PM. The adrenal cortex. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook of Endocrinology. 13th ed. Philadelphia, PA: Elsevier; 2016:490-555.
[8] Abraham GE. Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab. 1974;39(2):340-346.
[9] van der Veen JP, Schot LJ, Vemer HM, et al. Androstenedione secretion rates in normal subjects and in women with hyperandrogenism. J Clin Endocrinol Metab. 1977;45(5):768-772.
[10] McKenna TJ, O’Sullivan AJ, Heffernan A, Brady J, Cunningham SK. The production of androgens by normal and polycystic ovaries in vitro. Clin Endocrinol (Oxf). 1997;46(2):151-156.
[11] Balen AH, Conway GS, Kaltsas G, et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 1995;10(8):2107-2111.
[12] Witchel SF, Oberfield SE, Peña AS. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc. 2019;3(8):1545-1573.
[13] Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467-520.